BackCingulate Overview

Cingulate EBIT

Cingulate's EBIT is $-17M, above the sector sector average of $-63M.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$7.92M

As of Mar 31, 2026

Annual EBIT (TTM)

-$16.72M
99.75% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Cingulate (CING) FAQ

The latest EBIT for CING is $-17M as of March 2026. That compares with $-6.6B in the prior-year period — up 99.7% year over year. That is above the sector sector average of $-63M. Investors often review this figure alongside Cingulate's historical trend and sector peers before judging valuation or financial health.

Over the past year, CING's EBIT moved from $-6.6B to $-17M — a 99.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cingulate's operating scale or balance-sheet position.

Against its sector companies, CING currently prints $-17M for EBIT, while the sector average sits near $-63M. That is roughly 73.3% above the sector mean. Large gaps often invite a closer look at Cingulate's growth, margins, and balance sheet.

A EBIT figure of $-17M for CING is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-63M. Explore the charts below for those layers of context.

After noting CING's EBIT ($-17M), review year-over-year change from $-6.6B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.